![]() |
BHC | Bausch Health Companies Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ -0.14 |
Leverage | 101.21% |
Market Cap | $ 2.3B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -48.0m |
Margin | -0.51% |
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.